Corporate Governance
& Policy Documents

Since our inception in 1978, Duopharma Biotech has been a responsible, committed and equitable corporate citizen. Our business, operations and products aim to uphold the highest standards of quality, ethics and compliance, delivering trust and value to our consumers, caregivers, investors, the supply chain and other stakeholders.

Our Corporate Governance and Policy Documents guide our people, operations and practices in all aspects of our business, in all the markets we operate in.

  • Terms of Reference of the Audit Committee -English
  • Terms of Reference of the Nomination & Remuneration Committee -English
  • Terms of Reference of the Risk Management Committee -English
  • Terms of Reference of the Halal & Sustainability Committee -English
  • Terms of Reference of the Medical and Research Committee -English
  • Anti Bribery Management System Objectives -English
  • Anti Bribery Management System Policy -English
  • Integrity Pact Policy –English
  • Investigation Procedure –English
  • Organisational integrity and Anti-Corruption Plan 2021-2023 –English
  • Note on Animal Testing –English
  • Duopharma (M) Sendirian Berhad Quality Policy -English
  • Duopharma Manufacturing (Bangi) Sdn. Bhd. Quality Policy -English
  • Grant, Charitable Donations and External Sponsorship Policy –English
  • Remuneration Policy and Procedures for Directors and Senior Management –English
  • Policy on External Auditor –English
  • Diversity Policy for the Board of Directors and Senior Management –English
  • Fit and Proper Policy for the Board of Directors and Senior Management –English
  • Shareholders and Investors Communication Policy –English
  • Corporate Disclosure Policies & Procedures –English
  • Corporate Social Responsibility (CSR) Policy –English
  • Halal Policy –English
  • Record Retention Policy –English
  • Security Policy –English